Josh Davis

I am an established and highly productive early career clinical researcher, as evidenced by my outputs since being awarded my PhD in 2011: over 80 peer-reviewed published papers, which have been collectively cited over 2,000 times, giving me a 5-year h-index of 23, and research presentations at over 20 national and international scientific conferences. I have also attracted continuous people support funding from the NH&MRC from 2007 onwards (PhD Scholarship, ECF and CDF) and am currently a chief investigator on 4 NH&MRC project grants worth over $7 million and 5 current other competitive grants worth over $260,000. I have achieved this whilst having an approximate half-time commitment as a senior clinician, and developing leadership roles in the Australian infectious diseases (ID) community. These include being elected as president of the Australasian Society for Infectious Diseases (ASID), playing a key role in establishing the ASID clinical research network (CRN) and being selected for the expert writing group of Therapeutic Guidelines: Antibiotic, Australia’s national antibiotic policy.

My key areas of research interest are clinical trials in severe infectious diseases, aiming to address the many evidence gaps in clinical management of Staph aureus blood stream infection, bone and joint infections, and severe sepsis. I also have ongoing clinical and research interests in viral hepatitis and Aboriginal Health.